L. Zhang v. WCAB (Penn State Milton S. Hershey MC and Inservco Ins. Svcs.)

CourtCommonwealth Court of Pennsylvania
DecidedAugust 5, 2015
Docket2151 C.D. 2014
StatusUnpublished

This text of L. Zhang v. WCAB (Penn State Milton S. Hershey MC and Inservco Ins. Svcs.) (L. Zhang v. WCAB (Penn State Milton S. Hershey MC and Inservco Ins. Svcs.)) is published on Counsel Stack Legal Research, covering Commonwealth Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
L. Zhang v. WCAB (Penn State Milton S. Hershey MC and Inservco Ins. Svcs.), (Pa. Ct. App. 2015).

Opinion

IN THE COMMONWEALTH COURT OF PENNSYLVANIA

Lianqin Zhang, : Petitioner : : v. : No. 2151 C.D. 2014 : Submitted: May 29, 2015 Workers’ Compensation : Appeal Board (Penn State Milton : S. Hershey Medical Center and : Inservco Insurance Services), : Respondents :

BEFORE: HONORABLE DAN PELLEGRINI, President Judge HONORABLE P. KEVIN BROBSON, Judge HONORABLE JAMES GARDNER COLINS, Senior Judge

OPINION NOT REPORTED

MEMORANDUM OPINION BY JUDGE BROBSON FILED: August 5, 2015

Petitioner Lianqin Zhang (Claimant), pro se, petitions for review of an order of the Workers’ Compensation Appeal Board (Board), which affirmed the decision of a Workers’ Compensation Judge (WCJ). The WCJ denied Claimant’s claim petition. We now affirm. Claimant was employed by Penn State Milton S. Hershey Medical Center (collectively with Inservco Insurance Services, Employer) as an electron microscopy (EM) technician. Claimant’s job duties included processing tissue samples. Claimant worked in three rooms in Employer’s lab: the dark room, the EM room, and the sample processing room. Work in the sample processing room included the use of various chemicals, but the room contained a fume hood, which shielded employees from the chemicals. Claimant also worked with chemicals in the dark room where there was no fume hood. During the course of her employment, Claimant was exposed to nineteen different chemicals. Claimant began to develop symptoms, and, on September 29, 2011, she filed a claim petition alleging that she had sustained a “[r]espiratory tract injury with asthma; gastritis; anemia; and depression related to chemical exposure at work.” (Certified Record (C.R.) at 1.)1 Employer filed an answer denying the material allegations of Claimant’s claim petition, and the matter was assigned to a workers’ compensation judge (WCJ). At the hearing before the WCJ, Claimant testified that she worked for Employer for six months—from February 14, 2011, through August 10, 2011. (Notes of Testimony (N.T.), 8/2/12, at 12.) Claimant testified that the fume hood in the sample processing room consisted of a deflector shield and a sash. (Id. at 19.) When she worked, the sash was raised and her hands were in direct contact with the materials with which she was working. (Id.) Claimant felt that her breathing was obstructed in the sample processing room. (Id. at 27.) Employer did not provide Claimant with safety training or warnings concerning the exposure to chemicals. (Id. at 29-30.) Although Claimant wore a lab coat and gloves in the sample processing room, Employer did not provide her with additional protective gear. (Id. at 30.) Claimant worked five-to-seven hours a day in the sample processing room. (Id. at 31.) In the dark room, Claimant developed films from the electron microscope. (Id. at 33.) Her work involved processing film in various

1 By Order dated May 5, 2015, this Court granted a motion which excused Claimant from filing a reproduced record.

2 solutions, which were placed in open pans. (Id.) Because the pans were open, Claimant was exposed to the chemical fumes emanating from the solutions. (Id.) Claimant spent three-to-four hours a day in the dark room. (Id. at 33-34.) Claimant began to develop symptoms, such as chest pain, one or two weeks after she began working for Employer. (Id. at 50.) She lost her sense of both taste and smell in June 2011. (Id.) In May 2011, Claimant told her supervisor, Patricia Karlisch, that Claimant believed her symptoms were work-related. (Id. at 53.) Claimant then developed depression and asthma, which she also believed to be work-related. (Id. at 80-83.) Ms. Karlisch directed Claimant to visit a panel physician, who ultimately advised that Claimant could work full duty but should refrain from working with chemicals. (Id. at 60-67.) Claimant’s primary care physician and Claimant’s pulmonologist, Rebecca Bascom, M.D., both recommended medical leave. (Id. at 70-74.) Employer granted Claimant an extended leave of absence, but Employer terminated her employment on November 28, 2011, because she failed to return to work. (Id. at 78-79.) Claimant’s symptoms did not improve after her employment was terminated, even after mold was removed from her home. On February 10, 2012, the Occupational Safety and Health Administration (OSHA) cited Employer for, inter alia, failing to maintain the fume hood in good, working condition, failing to monitor Claimant for signs of chemical exposure, and failing to train Claimant about the hazards of chemical exposure. (C.R., OSHA Inspection Detail.) Claimant presented the deposition testimony of Margit Bleecker, M.D., Stella Hines, M.D., Barbara Kuhlengel, M.D., and Michael Geppert. Dr. Bleecker diagnosed Claimant with severe clinical depression and encephalopathy from toxic exposure. (Bleecker Dep. at 19, 25.) Dr. Hines

3 diagnosed Claimant with occupational asthma. (Hines Dep. at 22.) Dr. Kuhlengel diagnosed Claimant with major depressive disorder and acute stress disorder. (Kuhlengel Dep. at 12.) All three doctors testified that Claimant’s conditions were work-related. Michael Geppert, whose company tested the sample processing room fume hood on April 9, 2010, and October 3, 2011, testified that the fume hood did not meet the American National Standards Institute (ANSI) standards for laboratory fume hood air flow during the April 2010 inspection. (Geppert Dep. at 7-8.) During the October 2011 inspection, the fume hood only passed inspection because the sash was not opened widely. (Id. at 13-14.) Despite the failure to conform to ANSI standards, air was still flowing through the fume hood. (Id. at 21-22.) Ms. Karlisch and Douglas Kuhn, Ph.D., testified before the WCJ on behalf of Employer. Ms. Karlisch testified that despite Claimant’s contentions, Employer provided Claimant with protective safety gear, including a lab coat, gloves, splash shield, and a safety mask. (N.T., 10/31/12, at 59, 64.) Ms. Karlisch further testified that Employer warned Claimant about the hazardous chemicals, as signs were posted in the lab area and Claimant signed the material safety data sheets (MSDS), which provided all relevant information about the chemicals. (Id. at 56.) Claimant also received safety training concerning the use of some of the chemicals. (Id. at 17-18.) Claimant did not inform Ms. Karlisch that she believed her symptoms to be work-related until July 2011. (Id. at 68.) Although Claimant testified that she worked in the sample processing room for five-to-seven hours a day, Ms. Karlisch explained that such a schedule was not possible given Claimant’s time sheet. (Id. at 59-63.) Dr. Kuhn testified that the fume hood did not meet institutional standards in April 2010 and July 2011, but it did meet

4 institutional standards in November 2010. (N.T., 12/4/12, at 12-14.) Even when the fume hood did not meet institutional standards, air was always flowing through it. (Id. at 16-17.) Employer presented the deposition testimony of Jeff Marshalek, Scott Manaker, M.D., and Wolfram Rieger, M.D. Mr. Marshalek testified that his job duties include testing the ventilation in Employer’s facility. (Marshalek Dep. at 7.) After testing the dark room ventilation on August 9, 2011, Mr. Marshalek found that the ventilation exceeded minimum requirements. (Id. at 11.) Dr. Rieger testified that he performed an independent psychiatric evaluation of Claimant. He diagnosed Claimant with somatoform disorder, which was unrelated to her employment. (Rieger Dep. at 43, 65-66.) Claimant did not suffer from clinical depression or anxiety. (Id. at 41-42.) Dr. Rieger explained that somatization occurs when inner conflict is expressed through vague, physical complaints. (Id. at 42.) He opined that Claimant could function well in a related field. (Id. at 45.) Dr. Manaker also opined that Claimant was expressing symptoms of somatization, although he linked it to major depression. (Manaker Dep.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cruz v. Workers' Compensation Appeal Board
728 A.2d 413 (Commonwealth Court of Pennsylvania, 1999)
LeDonne v. Workers' Compensation Appeal Board
936 A.2d 124 (Commonwealth Court of Pennsylvania, 2007)
Daniels v. Workers' Compensation Appeal Board
828 A.2d 1043 (Supreme Court of Pennsylvania, 2003)
Gibson v. Workers' Compensation Appeal Board
861 A.2d 938 (Supreme Court of Pennsylvania, 2004)
Benson v. Workmen's Compensation Appeal Board
668 A.2d 244 (Commonwealth Court of Pennsylvania, 1996)
Sergeant v. Workmen's Compensation Appeal Board
686 A.2d 902 (Commonwealth Court of Pennsylvania, 1996)
Cittrich v. Workmen's Compensation Appeal Board
688 A.2d 1258 (Commonwealth Court of Pennsylvania, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
L. Zhang v. WCAB (Penn State Milton S. Hershey MC and Inservco Ins. Svcs.), Counsel Stack Legal Research, https://law.counselstack.com/opinion/l-zhang-v-wcab-penn-state-milton-s-hershey-mc-and-inservco-ins-svcs-pacommwct-2015.